ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: biotechnology

Biotech spinoff using rabbit antibody platform to develop new cancer drugs raises $15M

Biotech spinoff using rabbit antibody platform to develop new cancer drugs raises $15M

May 21, 2013 12:08 pm by | 0 Comments

A spinoff of Epitomics (now owned by Abcam) that’s using the biotech’s rabbit monoclonal antibody technology to discover and develop new cancer drugs has raised at least $15 million.According to ... Read more
Biotech, meet service provider. This startup strives to streamline the process of outsourcing

Biotech, meet service provider. This startup strives to streamline the process of outsourcing

May 17, 2013 11:26 am by | 1 Comments

The “virtual” business models that have become common in many biotech startups may allow companies to operate with less capital, but they also present their own set of challenges.One of ... Read more
Wow of the Week: Penn training dogs to detect ovarian cancer

Wow of the Week: Penn training dogs to detect ovarian cancer

May 11, 2013 8:52 am by | 2 Comments

Call it the furriest cancer diagnostic. University of Pennsylvania’s School of Veterinary Medicine, Penn Medicine and Monell Chemical Senses Center are collaborating to train dogs to detect ovarian cancer using ... Read more
RainDance Technolgies raises $20M to grow market for DNA sequencing tools

RainDance Technolgies raises $20M to grow market for DNA sequencing tools

April 29, 2013 4:28 pm by | 0 Comments

It seems like many of the ongoing developments in genetic research share one thing in common: the need for speed. RainDance Technologies, a life science company with DNA sequencing tools ... Read more
PA governor gets national biotech industry honor

PA governor gets national biotech industry honor

April 23, 2013 9:52 pm by | 0 Comments

Pennsylvania Gov. Tom Corbett accepted the Biotechnology Industry Organization’s 2013 governor award for his work supporting the growth of the life science industry in the state. He was presented with ... Read more
America is #1 in overall biotech innovation, but policy and stability is the big weak spot

America is #1 in overall biotech innovation, but policy and stability is the big weak spot

April 22, 2013 4:42 pm by | 0 Comments

America is tops in intellectual property protection, but Finland is catching up fast in every other category used to calculate Scientific American’s Worldview Report and Bio-Innovation Scorecard.The report was presented ... Read more
Texas company working on better breast implants from an inkjet printer

Texas company working on better breast implants from an inkjet printer

April 11, 2013 10:35 am by | 0 Comments

Print-your-own breast implants could be one of the new products in the $8.4 billion market of 3D printer products projected for 2025.TeVido BioDevices is working to commercialize technology that would ... Read more
Seattle biotech ups series B again to ID & develop antibodies as infectious disease therapies

Seattle biotech ups series B again to ID & develop antibodies as infectious disease therapies

March 29, 2013 4:52 pm by | 0 Comments

Seattle-based biotech Theraclone Sciences Inc. has added another $8 million to its series B as it advances two antibodies targeting viral infections through clinical development and works on identifying more.Existing ... Read more
Obama uses ROI of genome mapping to defend research funding at SOTU

Obama uses ROI of genome mapping to defend research funding at SOTU

February 13, 2013 1:39 am by | 2 Comments

President Barack Obama defended research funding against the potential cuts from the sequester. It was gratifying to see a clear illustration of the value of government research and government funding ... Read more
Biopharma adds $12M to advance “stapled peptide” technology to clinical trials

Biopharma adds $12M to advance “stapled peptide” technology to clinical trials

January 14, 2013 12:07 pm by | 0 Comments

Biopharmaceutical company Aileron Therapeutics Inc. is ready to advance what it says is a new class of drugs called stapled peptides into clinical trials after boosting its series D round ... Read more
Who are the top-earning R&D executives in biotech?

Who are the top-earning R&D executives in biotech?

January 11, 2013 10:16 am by | 0 Comments

As biotech R&D spending grows, and a steady stream of biotech products continues to win regulatory approval, R&D executives at the companies commercializing these drugs have been rising accordingly.In a ... Read more
Drug discovery technology firm will expand its lab, staff with $4 million series C

Drug discovery technology firm will expand its lab, staff with $4 million series C

October 25, 2012 10:32 am by | 0 Comments

A Virginia-based company that creates cell systems to replicate human organ systems and diseases for drug discovery and development will expand its lab and staff with a $4 million series ... Read more
Valeant buys Visudyne drug from QLT; QLT stock jumps

Valeant buys Visudyne drug from QLT; QLT stock jumps

September 24, 2012 10:09 am by | 0 Comments

TORONTO (Reuters) - Valeant Pharmaceuticals International Inc said on Monday it has acquired Visudyne, a drug used to treat age-related blindness, from Canadian biotech firm QLT Inc for $112.5 million.QLT's ... Read more
Biotechnology firm raising $30M to advance treatment for Parkinson’s, neurodegenerative disease

Biotechnology firm raising $30M to advance treatment for Parkinson’s, neurodegenerative disease

July 13, 2012 1:59 pm by | 1 Comments

A biotechnology company that has licensed a drug for the treatment of neurodegenerative disease amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in phase 3 development withBiogen Idec (NASDAQ:BIIB) is raising ... Read more
Clinical trial technology company acquired in $400M private equity deal

Clinical trial technology company acquired in $400M private equity deal

April 10, 2012 6:40 pm by | 0 Comments

A clinical trial technology company that serves the biopharmaceutical and clinical research organization sectors has been acquired in a $400 million private equity deal.eResearch Technology (NASDAQ:ERT), a Philadelphia-based company, was ... Read more